Reflow’s Spur Stent System Evaluated for CLTI in 12-Month DEEPER REVEAL Data

April 13, 2026—Reflow Medical, Inc. announced 12-month results from the DEEPER REVEAL clinical trial.

Stryker to Acquire Amplitude Vascular Systems

April 13, 2026—Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a privately held company developing a next-generation intravascular lithotripsy (IVL) platform to treat calcified peripheral artery disease.

Microbot Liberty Endovascular Robotic System Launched With Full Market Release in the United States

April 13, 2026—Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral endovascular procedures.

Baylis Launches PowerWire 14 RF Guidewire to Treat Arterial and Venous Occlusions

April 7, 2026—Baylis Medical Technologies Inc. announced FDA 510(k) clearance and the commercial launch of the company’s PowerWire 14 radiofrequency (RF) guidewire, which is intended for use in both arterial and venous occlusions.

SirPAD Evaluates Concept Medical’s MagicTouch Sirolimus-Coated Balloon

April 1, 2026—Concept Medical Inc. announced the presentation of primary results of the SirPAD randomized controlled trial of the company’s MagicTouch sirolimus-coated balloon for percutaneous transluminal angioplasty (PTA) to treat peripheral artery disease (PAD).

Abbott’s Esprit BTK System Gains CMS Transitional Pass-Through Payment Status

March 24, 2026—Abbott announced that its transcatheter Esprit below-the-knee (BTK) everolimus-eluting resorbable scaffold system has been approved for transitional pass-through (TPT) payment status by the Centers for Medicare & Medicaid Services (CMS).

iVascular’s Luminor DCB for Femoropopliteal Disease Evaluated in LUMIFOLLOW Registry

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating the safety and efficacy of the Luminor paclitaxel drug-coated balloon (DCB) in the treatment of femoropopliteal artery disease.

Large Primary Care Study Outlines PAD Burden and Incidence in United States

January 28, 2026—In a retrospective cohort study examining patterns of peripheral artery disease (PAD) diagnosis in United States primary care settings, Nriagu et al identified substantial demographic, clinical, and socioeconomic disparities in PAD burden and observed a notable increase in PAD incidence following the COVID-19 pandemic.

Boston Scientific’s Seismiq Peripheral IVL System Introduced in Limited Market Release

January 22, 2026—Boston Scientific has initiated the limited market release of the Seismiq intravascular lithotripsy (IVL) system, marking the completion of the first peripheral cases using the device.

PAD Performance and Quality Measures Issued by ACC and AHA

January 8, 2026—The American College of Cardiology (ACC) and American Heart Association (AHA) have issued the “2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease (PAD).”

Management of PAD in Patients With Diabetes Addressed in ACC Scientific Statement

December 29, 2025—The American College of Cardiology (ACC) announced that a new scientific statement on the management of peripheral artery disease (PAD) in adults with diabetes was published by Sandeep R. Das, MD, et al in JACC.

Data From Medtronic’s French QoL Registry for In.Pact Admiral DCB Presented

December 16, 2025—Medtronic announced that results from the company-sponsored In.Pact Admiral drug-coated balloon (DCB) French Quality of Life (QoL) registry were presented by Professor Yann Gouëffic, MD, at the Paris Vascular Insights Course.

Medtronic’s Liberant Thrombectomy System Used in First Commercial Case

December 10, 2025—Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems.

Bendit17 Steerable Microcatheter Cleared by FDA

December 10, 2025—Bendit Technologies, an Israel-based developer of a steerable microcatheter platform, announced that the FDA has granted 510(k) clearance for the Bendit17 microcatheter for use in complex vascular procedures, including neurovascular and peripheral endovascular interventions.

Serum cFAS Shows Promise as a Diagnostic Marker in PAD and CLTI

December 8, 2025—In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD), Abu-Amer et al found that elevated cFAS levels were independently associated with both PAD and chronic limb-threatening ischemia (CLTI), with higher concentrations correlating with greater disease severity.

European Solaris SX Iliac Postmarket Study Presented With 12-Month Data

December 4, 2025—Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the company’s non–drug-eluting mechanical scaffold.

Philips Expands Commercial Availability of LumiGuide Light-Based 3D Navigation Solution 

December 1, 2025—Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United States.

Okami Medical Names Bill Hykes as CEO and Closes $45M Financing

November 25, 2025—Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and CEO of the company, while Bill Hoffman was appointed Chairman of the Board.

Pathfinder Medical Appoints Dr. Lorenzo Patrone as CMO

November 25, 2025—Pathfinder Medical, a United Kingdom-based developer of minimally invasive vascular access technologies, announced the appointment of Lorenzo Patrone, MD, as the company’s Chief Medical Officer.

Humacyte’s ATEV Evaluated After Long-Term Clinical Use

November 24, 2025—Humacyte, Inc. announced that multiple presentations on the company’s acellular tissue-engineered vessel (ATEV) were delivered at the VEITHsymposium.